KYTX
Price
$3.07
Change
-$0.21 (-6.40%)
Updated
Jun 30 closing price
Capitalization
132.25M
48 days until earnings call
MGX
Price
$1.48
Change
+$0.02 (+1.37%)
Updated
Jun 30 closing price
Capitalization
55.14M
43 days until earnings call
Interact to see
Advertisement

KYTX vs MGX

Header iconKYTX vs MGX Comparison
Open Charts KYTX vs MGXBanner chart's image
Kyverna Therapeutics
Price$3.07
Change-$0.21 (-6.40%)
Volume$452.83K
Capitalization132.25M
Metagenomi
Price$1.48
Change+$0.02 (+1.37%)
Volume$250.1K
Capitalization55.14M
KYTX vs MGX Comparison Chart in %
Loading...
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYTX vs. MGX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYTX is a StrongBuy and MGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (KYTX: $3.07 vs. MGX: $1.48)
Brand notoriety: KYTX and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYTX: 101% vs. MGX: 53%
Market capitalization -- KYTX: $132.25M vs. MGX: $55.14M
KYTX [@Biotechnology] is valued at $132.25M. MGX’s [@Biotechnology] market capitalization is $55.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYTX’s FA Score shows that 0 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • KYTX’s FA Score: 0 green, 5 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, both KYTX and MGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYTX’s TA Score shows that 3 TA indicator(s) are bullish while MGX’s TA Score has 5 bullish TA indicator(s).

  • KYTX’s TA Score: 3 bullish, 5 bearish.
  • MGX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MGX is a better buy in the short-term than KYTX.

Price Growth

KYTX (@Biotechnology) experienced а -4.66% price change this week, while MGX (@Biotechnology) price change was +4.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.71%. For the same industry, the average monthly price growth was +31.92%, and the average quarterly price growth was +6.10%.

Reported Earning Dates

KYTX is expected to report earnings on Aug 18, 2025.

MGX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+3.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($132M) has a higher market cap than MGX($55.1M). KYTX YTD gains are higher at: -17.914 vs. MGX (-59.003). MGX has higher annual earnings (EBITDA): -82.2M vs. KYTX (-143.14M). KYTX has more cash in the bank: 243M vs. MGX (226M). KYTX has less debt than MGX: KYTX (6.94M) vs MGX (44.4M). MGX has higher revenues than KYTX: MGX (45.3M) vs KYTX (0).
KYTXMGXKYTX / MGX
Capitalization132M55.1M240%
EBITDA-143.14M-82.2M174%
Gain YTD-17.914-59.00330%
P/E RatioN/AN/A-
Revenue045.3M-
Total Cash243M226M108%
Total Debt6.94M44.4M16%
TECHNICAL ANALYSIS
Technical Analysis
KYTXMGX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KYTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRCCX29.51N/A
N/A
Carillon ClariVest Capital Apprec C
GOGFX39.33N/A
N/A
Victory Sycamore Small Company Opp R
VARCX10.78N/A
N/A
First Trust Merger Arbitrage Cl C
POIRX16.43N/A
N/A
Polen International Growth Investor
VIKSX11.25N/A
N/A
Virtus KAR Small-Mid Cap Growth I

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with IPSC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
-6.40%
IPSC - KYTX
51%
Loosely correlated
+7.71%
CRSP - KYTX
48%
Loosely correlated
+4.15%
IMNM - KYTX
46%
Loosely correlated
+6.04%
TRDA - KYTX
45%
Loosely correlated
-2.75%
RXRX - KYTX
45%
Loosely correlated
+0.70%
More

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with KOD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
+1.37%
KOD - MGX
42%
Loosely correlated
+1.08%
KYTX - MGX
35%
Loosely correlated
-6.40%
SABS - MGX
34%
Loosely correlated
+3.85%
CVM - MGX
33%
Loosely correlated
-4.58%
CDXS - MGX
33%
Poorly correlated
+2.09%
More